Luke Hounsome

2.2k total citations · 1 hit paper
58 papers, 1.4k citations indexed

About

Luke Hounsome is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luke Hounsome has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luke Hounsome's work include Bladder and Urothelial Cancer Treatments (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Urinary and Genital Oncology Studies (11 papers). Luke Hounsome is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Urinary and Genital Oncology Studies (11 papers). Luke Hounsome collaborates with scholars based in United Kingdom, Sweden and United States. Luke Hounsome's co-authors include Julia Verne, Anna Gavin, P. R. Briddon, R. Jones, Dyfed Huws, Jon Shelton, Nick Ormiston‐Smith, Lucy Elliss‐Brookes, Ceri White and D M Parkin and has published in prestigious journals such as The Lancet, Physical Review B and British Journal of Cancer.

In The Last Decade

Luke Hounsome

56 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015

2018 357 citations Katrina Brown, Harriet Rumgay et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luke Hounsome United Kingdom	20	440	440	256	176	172	58	1.4k
Stephen R. Thompson Australia	15	206 0.5×	164 0.4×	316 1.2×	98 0.6×	81 0.5×	53	1.1k
Paul Gordon United States	18	100 0.2×	199 0.5×	115 0.4×	162 0.9×	177 1.0×	70	1.3k
Øystein E. Olsen United Kingdom	31	642 1.5×	165 0.4×	414 1.6×	382 2.2×	67 0.4×	79	3.1k
U. Haller Switzerland	26	706 1.6×	290 0.7×	585 2.3×	129 0.7×	108 0.6×	122	2.3k
Eugenio Ventimiglia Italy	30	358 0.8×	116 0.3×	1.2k 4.5×	363 2.1×	15 0.1×	187	2.9k
Carolyn L. Wang United States	24	402 0.9×	227 0.5×	407 1.6×	111 0.6×	160 0.9×	64	2.1k
N. Reed Dunnick United States	26	383 0.9×	256 0.6×	468 1.8×	205 1.2×	31 0.2×	96	2.0k
Wooju Jeong United States	25	895 2.0×	203 0.5×	1.5k 5.8×	363 2.1×	42 0.2×	94	2.1k
Jeffrey S. Montgomery United States	30	1.5k 3.4×	436 1.0×	1.5k 5.9×	165 0.9×	29 0.2×	158	3.1k
Robert Rutledge Canada	16	287 0.7×	211 0.5×	317 1.2×	431 2.4×	32 0.2×	33	1.3k

Countries citing papers authored by Luke Hounsome

Since Specialization

Citations

This map shows the geographic impact of Luke Hounsome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Hounsome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Hounsome more than expected).

Fields of papers citing papers by Luke Hounsome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Hounsome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Hounsome. The network helps show where Luke Hounsome may publish in the future.

Co-authorship network of co-authors of Luke Hounsome

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Hounsome. A scholar is included among the top collaborators of Luke Hounsome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Hounsome. Luke Hounsome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nonnenmacher, T. F., Diane Pople, Jack Pollard, et al.. (2025). Plasmid conjugation drives within–patient plasmid diversity. Microbial Genomics. 11(3). 1 indexed citations

Hounsome, Luke, et al.. (2024). Epidemiological impact of a large number of false negative SARS-CoV-2 test results in South West England during September and October 2021. Epidemics. 46. 100739–100739. 1 indexed citations

Panovska‐Griffiths, Jasmina, Nicholas A. Watkins, Luke Hounsome, et al.. (2023). Responsive modelling of the mpox epidemic in England as a cross-government and academia collaboration: the process, challenges, and lessons learned. The Lancet Microbe. 4(9). e658–e660. 6 indexed citations

White, R. J., Fintan Stanley, Archie Macnair, et al.. (2021). Treatable but not curable cancer in England: a retrospective cohort study using cancer registry data and linked data sets. BMJ Open. 11(1). e040808–e040808. 28 indexed citations

Catto, James W.F., Amy Downing, Samantha J. Mason, et al.. (2021). Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes. European Urology. 79(5). 621–632. 96 indexed citations

Mason, Samantha J., Amy Downing, Sarah Wilding, et al.. (2021). Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort. Supportive Care in Cancer. 30(4). 3151–3164. 1 indexed citations

Smith, Lesley, Amy Downing, Paul Norman, et al.. (2020). Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based study. Cancer Epidemiology. 69. 101830–101830. 7 indexed citations

Wright, Penny, Sarah Wilding, Eila Watson, et al.. (2019). Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study. Cancer Epidemiology. 60. 201–207. 10 indexed citations

Wilding, Sarah, Amy Downing, Penny Wright, et al.. (2019). Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. Quality of Life Research. 28(10). 2741–2751. 26 indexed citations

10.

Mason, Samantha J., Amy Downing, Penny Wright, et al.. (2018). Health-related quality of life after treatment for bladder cancer in England. British Journal of Cancer. 118(11). 1518–1528. 52 indexed citations

11.

Brown, Katrina, Harriet Rumgay, Alison Cox, et al.. (2018). The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British Journal of Cancer. 118(8). 1130–1141. 357 indexed citations breakdown →

12.

Kaushik, Sonali, et al.. (2018). The Impact of Sociodemographic Factors and Emergency Admissions on the Place of Death of Gynecological Cancer Patients in England: An Analysis of a National Mortality–Hospital Episode Statistics–Linked Data Set. International Journal of Gynecological Cancer. 28(9). 1714–1721. 1 indexed citations

13.

Merriel, Samuel WD, Emma L. Turner, Eleanor Walsh, et al.. (2017). Cross-sectional study evaluating data quality of the National Cancer Registration and Analysis Service (NCRAS) prostate cancer registry data using the Cluster randomised trial of PSA testing for Prostate cancer (CAP). BMJ Open. 7(11). e015994–e015994. 12 indexed citations

14.

Thorn, Joanna, Emma L. Turner, Luke Hounsome, et al.. (2016). Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). BMJ Open. 6(4). e011063–e011063. 26 indexed citations

15.

Ranasinghe, Weranja, Daswin De Silva, Benjamin Ayres, et al.. (2015). Trends in penile cancer: a comparative study between Australia, England and Wales, and the US. SpringerPlus. 4(1). 420–420. 26 indexed citations

16.

Hounsome, Luke, et al.. (2015). Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Medicine. 13(1). 171–171. 71 indexed citations

17.

Thorn, Joanna, Emma L. Turner, Luke Hounsome, et al.. (2015). Validation of the Hospital Episode Statistics Outpatient Dataset in England. PharmacoEconomics. 34(2). 161–168. 29 indexed citations

18.

Thorn, Joanna, Emma L. Turner, Luke Hounsome, et al.. (2014). Validation of The Hospital Episode Statistics Outpatient Dataset in England. Value in Health. 17(7). A547–A548. 1 indexed citations

19.

Hounsome, Luke, Gary Abel, Julia Verne, David E. Neal, & Georgios Lyratzopoulos. (2013). Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: data from a pilot study of 1756 cases 2004–2011. British Journal of Urology. 111(7). 1061–1067. 4 indexed citations

20.

McCabe, John E., et al.. (2011). UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database. British Journal of Urology. 109(3). 346–354. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact